Trials / Completed
CompletedNCT01406652
Optimisation of the Treatment of Infectious Bursitis
One-stage Versus Two-stage Surgical Treatment of Infectious Bursitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 224 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates prospectively the cost-savings related to a one-stage bursectomy (debridement, drainage and closure at the same time) versus two-stage bursectomy (debridement, left open and closure at a second time) of severe bursitis among hospitalized patients for surgical treatment of septic bursitis. We suppose that the one-stage bursectomy reveals similar recurrence rates but is associated with a significant shortening of hospital stay, consumption of resources and increased patient satisfaction.
Detailed description
Start as single center interventional study at Geneva University Hospitals Study open for additional centres (electronic CRF) Funding on 24.6.2011 (50,000 Swiss Francs). Further demand for funding ongoing. Septic bursitis of knee and elbows, for which the patients are hospitalised (a substantial part of patient with failure of conservative treatment) Randomisation 1:1 (one-stage vs. two-stage). Duration of concomitant postsurgical antibiotic therapy fixed to 7 days Exclusion of severely immuno-depressed patients. Assessment of all costs of inpatient treatment and outpatient follow-up of included cases. Interim analysis after ca. 100 cases planified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Two-stage bursectomy | Debridement, drainage, and secondary closure of septic bursitis during two surgical interventions |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2011-08-01
- Last updated
- 2019-12-02
- Results posted
- 2019-11-05
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01406652. Inclusion in this directory is not an endorsement.